Welcome to the official website of Chengdu Chuanghe Biotechnology Co., Ltd.!
Contact Us
Chengdu chuanghefeng Biotechnology Co., Ltd
Telephone:17380589800
Landline:028-85542899
Mailbox:zengqs@chf2018.com
Address: Building 16, Phase II of "Strait SME Incubation Park", No. 188, West Section of Kexing Road, Wenjiang District, Chengdu
Website:www.chf2018.com
1. Cardiac rehabilitation machine production capacity, price and delivery period:
Disposable hollow chemical fiber hemodiaplasm assembly production line
1. Trial production line: 300,000/year
2. Batch production line: 1 million/year
3. Batch production line: 3 million/year
Hematopolysis device hollow chemical fiber spinning machine production line
1. 32 Swilish head test production line: 100,000/year/year
2. 320 spraying silk head production line: 1 million/year
3. 960 spraying silk head production line: 3 million/year
2. Sales market narrative:
According to the population of about 20-35 million in chronic renal patients in 2016, 4 million patients must have dialysis, and develop each year at a rate of 6-8 %.
At this stage, a 1/4 dialysis population is abroad. The US government spends 40 billion US dollars per year for kidney dialysis; as if it is accompanied by the improvement of the chronic population and the implementation of the health insurance, the 15 kidney -washing population and cost fee are all the costs and cost fees are all the costs and cost fees. Fast accumulation.
The Journal of Economics Magazine Magazine in the United States describes the market prospects of all industrial chains with a rapidly developing dialysis sales market. The market capacity is from 63.3 billion US dollars in 2009 to $ 83.6 billion in 2013, and patients with chronic renal failure 2020 The annual meeting has grown to 4 million people, and the majority of most of the patients are added. It is mainly due to the improvement and improvement of this good life and diet in my country in recent years.
Taiwan is a area with a high incidence of diabetes and a high rate of popularity. In 2013, the annual demand for 67,000 dialysis patients and 8 million dialy -dialysis patients in the Executive Yuan of the Executive Yuan ranked seventh. The cost of Health Insurance will cost 40 billion yuan per year, and it will be paid for large single engineering diseases.

kidney dialysis must be 1500-2 million people. It is expected that 250-3 million people may be developed in 5 years, becoming*, and the market prospects are great.
3. Machinery and equipment narrative:
Automatic hemodiaplasposter spinning production line and hemodiaplane assembly production lines are suitable for assembly of all membrane products. A full set of processing processes include shell laser marking, infrared burn, centrifugal gels, dried products, membrane wire cuts, product testing, product testing Leakage, commodity drying treatment, torque coverage, structural water pressure test, packaging design.
4. Disposable hollow chemical fiber hemodiaplasm assembly production line technical advantages
Everyone grasped the product research and development and production technology of hemodialysis (bionic eye) production line machinery and equipment, and thoroughly grasped the production process and quality control system of hemodialysis device based on many years of practical activities.
At the same time, everyone has the key ingredients (PS), polyether (PES) membrane low diffusion coefficient, high -throughput sequencing secret recipe data information and technical nature of the manufacturer of hemodiaplasm, and the high -throughput sequencing secret recipes. Technical solution and EPC general contract.
At the same time, everyone grasps the development and design of the hemodialysis machine, the bloody night centrifugal fume purifier and the technical nature of the heart rehabilitation consumable.